肛提肌外腹会阴联合切除术与传统的腹会阴联合切除术对远端直肠癌患者疗效的Meta分析

摘要

Objective To explore the short and long-term efficacy of extralevator abdominoperineal excision (ELAPE)vs.conventional abdominoperineal excision (APE)on distal rectal cancer.Methods Relevant studies were identified by search of Medline,EMBASE,and Web of Science published between January 1,2008 and February 28,2015,and included in the systematic review and meta-analysis with Stata software (version 12.0). Results Our Meta-analysis included 14 studies involving 3278 patients,of whom 1843 (56.2%)underwent ELAPE and 1435 (43.8%)underwent APE.Compared with patients undergoing APE,those undergoing ELAPE had a significantly reduced risk of intraoperative bowel perforation (IBP)involvement (OR=0 .55 ,95% CI= 0 .37-0 .85 ),but no significant reduction in the occurrence of CRM positivity (OR=0 .81 ,95% CI=0 .52-1 .25 ), local recurrence (LR)(OR=0.49,95% CI=0.18-1.30),wound complications (WCs)(OR=0.93,95% CI=0.65-1.35)or in-hospital death (IHD)(OR=0.89,95% CI=0.47-1.71).Conclusion ELAPE can reduce the risk of IBP but not for CRM positivity or LR when compared with APE.Therefore,more higher-quality studies are needed to verify the short-and long-term effects of ELAPE procedure on distal rectal cancer.%目的 探讨经提肛肌外腹会阴联合切除术(ELAPE)与传统的腹会阴联合切除术(APE)对远端直肠癌患者近远期疗效的影响.方法 采用Stata 12.0统计学软件对2008年1月1日至2015年2月28日间Medline、EMBASE等数据库收录的相关文献进行Meta分析.结果 共纳入14个研究包含3278例患者,其中56.2%(1843/3278)患者接受ELAPE手术,43.8%(1435/3278)患者接受APE手术,ELAPE手术患者术中肠穿孔(IBP)率为6.4%(114/1786),APE术式患者为10.7%(145/1355),合并OR值为0.55(95%CI=0.37~0.85),而环周切缘(CRM)阳性率、局部复发率(LR)、伤口并发症(WCs)、院内死亡(IHD)合并OR值分别为0.81(95%CI=0.52~1.25)、0.49(95%CI=0.18~1.30)、0.93(95%CI=0.65~1.35)、0.89(95%CI=0.47~1.71).结论 与APE术式相比,ELAPE术式可以降低IBP的风险,但并未改善CRM阳性率和LR.因此,ELAPE手术的近远期疗效尚待开展更多高质量研究加以验证.